You might also like

More about Novartis Foundation Symposium 229 - From Genome to Therapy - Integrating New Technologies with Drug Development

• Book details
• Synopsis
• Trending among others

You get 539 loyalty points

Book synopsis

This important and exciting work brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known for several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one. This major book covers such subjects as the current state of the art in squencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomics from the point of view of the pharmaceutical industry.

Book details

Book category Books in English Economics, finance, business & management Industry & industrial studies Manufacturing industries

• Full title: Novartis Foundation Symposium 229 - From Genome to Therapy - Integrating New Technologies with Drug Development
• Author: Novartis Foundation
• Language: English
• Binding: Hardback
• Number of pages: 174
• EAN: 9780471627449
• ISBN: 0471627445
• ID: 04892599
• Publisher: John Wiley & Sons Inc
• Weight: 380 g
• Dimensions: 233 × 165 × 18 mm
• Date of publishing: 27. September 2000

Trending among others

---

---

---